Periodic Reporting for period 1 - NeuroLSD (Neuro-metabolic, structural and functional hallmarks of Lysosomal Storage Diseases)

Continuing development of novel brain treatments, which aim to overcome blood-brain barriers (BBB), further emerges the need to establish prognostic magnetic resonance (MR) markers to track progressive central nervous system (CNS) deficits in lysosomal storage diseases(LSD)...